Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YZJ-1139 in Insomnia Disorder
NCT05525637Phase 3Completed
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Start
- Dec 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fazamorexant in insomnia disorder, sponsored by Shanghai Haiyan Pharmaceutical Technology Co., Ltd.. Started Dec 2021; status: completed.
02
Drugs
fazamorexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT05525637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05525637.